0001367644-21-000144.txt : 20211115 0001367644-21-000144.hdr.sgml : 20211115 20211115175315 ACCESSION NUMBER: 0001367644-21-000144 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211115 FILED AS OF DATE: 20211115 DATE AS OF CHANGE: 20211115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LINDAHL RICHARD S CENTRAL INDEX KEY: 0001196632 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 211413035 MAIL ADDRESS: STREET 1: NEXTEL STREET 2: 2001 EDMUND HALLEY DR CITY: RESTON STATE: VA ZIP: 20191 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 wf-form4_163701676472498.xml FORM 4 X0306 4 2021-11-15 0 0001367644 Emergent BioSolutions Inc. EBS 0001196632 LINDAHL RICHARD S 400 PROFESSIONAL DRIVE, SUITE 400 GAITHERSBURG MD 20879 0 1 0 0 EVP, Chief Financial Officer Common Stock 2021-11-15 4 P 0 3000 37.46 A 39919 D The price reported is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $37.32 to $37.63. /s/ S. Scott Lieberman, Attorney-in-fact 2021-11-15